SEC Filings
US Foods Adds A Technology Investor To Oversee Its AI And Growth Strategy
The board appointment follows restaurant-volume gains and a tighter full-year outlook tied to a slower economy and higher fuel costs.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
SEC Filings
The board appointment follows restaurant-volume gains and a tighter full-year outlook tied to a slower economy and higher fuel costs.
Insider Trades
The chairman and CEO exercised options for 40,000 shares Monday and sold the same number at an average $525.16.
Deals
The acquisition adds a third clinical-stage candidate, with sellers eligible for up to $48 million in development and regulatory milestones.
SEC Filings
Early bladder-cancer follow-up showed lasting responses, but two patients progressed to muscle-invasive disease.
Deals
The buyer's payment is expected to count toward Fulcrum's net cash under its proposed merger with Slate Medicines.
SEC Filings
Substantially all company and guarantor assets back the borrowing obligations, with leverage limits governing access to debt.
SEC Filings
Intel and Boston Scientific share counts rose as the disclosed U.S. stock portfolio fell to $161.3 billion.
SEC Filings
Management expects cash and collaboration payments to cover operations at least into the second half of 2028, beyond planned 2027 trial results.
SEC Filings
The firm trimmed its S&P 500 ETF shares and doubled its Nvidia holding, while increasing put exposure to Nvidia and AMD.
SEC Filings
Manufacturing-sale proceeds and partner payments added cash as smaller milestones pushed quarterly revenue lower.
SEC Filings
Meta, Amazon, Apple and Broadcom holdings also contracted, while the disclosed portfolio grew to $73.4 billion.
SEC Filings
An illustrative launch timetable puts first treatments and revenue three to six months after potential approval.